4-[(3-amino-6-bromo-4-quinolinyl)amino]-.alpha.,.alpha.-dimethyl-Benzeneacetonitrile

2-(4-((3-Amino-6-bromoquinolin-4-yl)amino)-phenyl)-2-methylpropanenitrile is used as a reagent in the preparation of imidazo quinoline derivatives, compounds that act as mammalian target of rapamycin (mTOR) an phosphatidylinositol 3-kinase (PI3K-kinase) inhibitors.